Breaking News Instant updates and real-time market news.

RF

Regions Financial

$10.01

-0.04 (-0.40%)

06:29
10/18/16
10/18
06:29
10/18/16
06:29

Regions Financial sees 'modest' improvement in net interest income in Q4

Says plans to increase $300M expense elimination by $100M through 2019, totaling 11.5% of adjusted expenses. Says will accelerate savings where possible. Says continues to exercise caution and remain focused on prudent and quality loan growth with an emphasis on diversification and appropriate risk-adjusted returns. Given the recent moves to modestly higher long-term rates, expects $4M-$6M of improvement in premium amortization during the Q4. Excluding impact of the leveraged lease adjustment, expects modest improvement in net interest income and other financing income in Q4 and for margin to be relatively stable. Says "focused on what we can control in an uncertain environment." For 2016, expects "relatively stable" average loan growth and average deposits. Sees 2016 NII and other financing income up 2%-4% and adjusted non-interest income growth of over 6%. Sees 2016 adjusted expenses flat to up modestly, efficiency ratio about 63%, adjusted operating leverage of 2%-4% and net charge-offs of 25-35bps. Comments from slides that will be presented on the Q3 earnings conference call.

  • 04

    Nov

RF Regions Financial
$10.01

-0.04 (-0.40%)

10/11/16
FBRC
10/11/16
DOWNGRADE
Target $10.5
FBRC
Market Perform
Regions Financial downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Steve Moss downgraded Regions Financial to Market Perform after assuming coverage of the name from Paul Miller. He has a $10.50 price target for the shares. The analyst cites slower loan growth for his more conservative revenue outlook relative to consensus.
10/06/16
WEDB
10/06/16
INITIATION
Target $12
WEDB
Outperform
Regions Financial initiated with an Outperform at Wedbush
Wedbush analyst Peter Winter initiated Regions Finacial with an Outperform and a $12 price target.
10/06/16
WEDB
10/06/16
INITIATION
WEDB
Outperform
Citizens Financial initiated with an Outperform at Wedbush
Wedbush analyst Peter Winter initiated coverage of 14 regional and Texas banks, starting Citizens Financial (CFG) with an Outperform rating. The other three banks on which Winter assigned an Outperform rating are KeyCorp (KEY), Huntington Bancshares (HBAN) and Regions Financial (RF).
10/06/16
RAJA
10/06/16
DOWNGRADE
RAJA
Outperform
Regions Financial downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst David Long downgraded Regions Financial to Outperform due to strong share performance and maintained its $10.50 price target.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$740.34

-3.31 (-0.45%)

11:32
12/05/16
12/05
11:32
12/05/16
11:32
Hot Stocks
Amazon confirms Amazon Go 'store with no checkout required' »

Amazon announces Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNX

Knight Transportation

$36.45

0.45 (1.25%)

11:31
12/05/16
12/05
11:31
12/05/16
11:31
Conference/Events
Knight Transportation management to meet with Stephens »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBR

Nabors Industries

$17.50

0.445 (2.61%)

11:30
12/05/16
12/05
11:30
12/05/16
11:30
Options
Calendar spreads in Nabors trading with hefty markup »

Calendar spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:30
12/05/16
12/05
11:30
12/05/16
11:30
General news
Treasury Futures Action: a large block purchase of Ultra bonds »

Treasury Futures Action:…

ABMD

Abiomed

$108.87

1.48 (1.38%)

11:26
12/05/16
12/05
11:26
12/05/16
11:26
Conference/Events
Abiomed management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

DISCA

Discovery

$26.60

-0.55 (-2.03%)

11:25
12/05/16
12/05
11:25
12/05/16
11:25
Hot Stocks
Breaking Hot Stocks news story on Discovery »

Discovery up nearly 3% as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SUM

Summit Materials

$23.46

0.2 (0.86%)

11:20
12/05/16
12/05
11:20
12/05/16
11:20
Conference/Events
Summit Materials management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

P

Pandora

$13.59

0.255 (1.91%)

11:20
12/05/16
12/05
11:20
12/05/16
11:20
Options
Bullish option play opened in Pandora »

Bullish option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISCA

Discovery

$26.60

-0.55 (-2.03%)

, T

AT&T

$38.75

0.14 (0.36%)

11:18
12/05/16
12/05
11:18
12/05/16
11:18
Hot Stocks
Discovery CEO says 'well positioned' to take product direct to consumer in 2017 »

Discovery (DISCA) says…

DISCA

Discovery

$26.60

-0.55 (-2.03%)

T

AT&T

$38.75

0.14 (0.36%)

TWX

Time Warner

$93.84

0.04 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

SCG

SCANA

$70.63

-0.29 (-0.41%)

11:18
12/05/16
12/05
11:18
12/05/16
11:18
Hot Stocks
SCANA, Westinghouse receive order from DRB about construction milestone payment »

South Carolina Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$30.86

0.06 (0.19%)

11:18
12/05/16
12/05
11:18
12/05/16
11:18
Hot Stocks
BeiGene: BGB-3111 'highly active' in CLL/SLL, well tolerated in Phase 1 study »

BeiGene presented updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

NKE

Nike

$51.77

1.31 (2.60%)

11:16
12/05/16
12/05
11:16
12/05/16
11:16
Technical Analysis
Nike moves to monthly highs, levels to watch »

The stock is up over 3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

TGTX

TG Therapeutics

$5.50

0.05 (0.92%)

11:16
12/05/16
12/05
11:16
12/05/16
11:16
Hot Stocks
TG Therapeutics announces oral data presentation for TGR-1202 at ASH »

TG Therapeutics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

$NYE

NYSE Market Internals

11:16
12/05/16
12/05
11:16
12/05/16
11:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:16
12/05/16
12/05
11:16
12/05/16
11:16
Technical Analysis
NASDAQ market internals summary »

Volume is very light for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$13.00

0.2 (1.56%)

11:15
12/05/16
12/05
11:15
12/05/16
11:15
Periodicals
New York Times sees more-than-tenfold increase in daily subs, Politico reports »

The New York Times has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

11:15
12/05/16
12/05
11:15
12/05/16
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
12/05/16
12/05
11:15
12/05/16
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

11:14
12/05/16
12/05
11:14
12/05/16
11:14
Recommendations
GW Pharmaceuticals analyst commentary  »

GW Pharmaceuticals price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

ORA

Ormat Technologies

$47.50

0.17 (0.36%)

11:14
12/05/16
12/05
11:14
12/05/16
11:14
Conference/Events
Ormat Technologies management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

FGP

Ferrellgas Partners LP

$6.20

0.55 (9.73%)

11:13
12/05/16
12/05
11:13
12/05/16
11:13
Upgrade
Ferrellgas Partners LP rating change  »

Ferrellgas Partners LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ULTA

Ulta Beauty

$253.39

-4.02 (-1.56%)

11:12
12/05/16
12/05
11:12
12/05/16
11:12
Conference/Events
Ulta Beauty management to meet with Oppenheimer »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 13

    Dec

RSX

Market Vectors Russia ETF

$20.25

0.41 (2.07%)

11:10
12/05/16
12/05
11:10
12/05/16
11:10
Options
Bullish option action in the VanEck Vectors Russia Fund »

Bullish option action in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
12/05/16
12/05
11:10
12/05/16
11:10
General news
Treasury announced a $45 B 4-week bill sale for Tuesday »

Treasury announced a $45…

CDK

CDK Global

$56.91

-0.24 (-0.42%)

11:07
12/05/16
12/05
11:07
12/05/16
11:07
Conference/Events
CDK Global management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.